Literature DB >> 20380966

Outcome and cost of aneurysmal subarachnoid hemorrhage.

André A le Roux1, M Christopher Wallace.   

Abstract

Aneurysmal subarachnoid hemorrhage (aSAH) is a neurosurgical catastrophe. It affects 33,000 patients in the United States annually and has a mortality rate of 50% to 60% at 30 days. Half of the survivors are dependent. Outcome is closely related to the level of consciousness at the time of presentation, global cerebral edema, subarachnoid blood load as seen on CT, and rehemorrhage. Age, hyperglycemia, and medical complications are associated with worse outcomes. The cost impact factor of this condition is high from a financial perspective as well as from a patient perspective. Care givers show increased morbidity when compared with the nonaffected community. Early aggressive treatment of good grade patients seems to provide the best outcome for this serious condition. Copyright 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20380966     DOI: 10.1016/j.nec.2009.10.014

Source DB:  PubMed          Journal:  Neurosurg Clin N Am        ISSN: 1042-3680            Impact factor:   2.509


  21 in total

1.  Cell death starts early after subarachnoid hemorrhage.

Authors:  Victor Friedrich; Rowena Flores; Fatima A Sehba
Journal:  Neurosci Lett       Date:  2012-01-24       Impact factor: 3.046

2.  Therapeutic hypothermia for neuroprotection: history, mechanisms, risks, and clinical applications.

Authors:  Lioudmila V Karnatovskaia; Katja E Wartenberg; William D Freeman
Journal:  Neurohospitalist       Date:  2014-07

Review 3.  Intraoperative Targeted Temperature Management in Acute Brain and Spinal Cord Injury.

Authors:  Jacqueline Kraft; Anna Karpenko; Fred Rincon
Journal:  Curr Neurol Neurosci Rep       Date:  2016-02       Impact factor: 5.081

4.  Intracranial hypertension in patients with aneurysmal subarachnoid hemorrhage: a systematic review and meta-analysis.

Authors:  William A Florez; Ezequiel García-Ballestas; Harsh Deora; Amit Agrawal; Rafael Martinez-Perez; Sagar Galwankar; Ravish Keni; Geetha R Menon; Andrei Joaquim; Luis-Rafael Moscote-Salazar
Journal:  Neurosurg Rev       Date:  2020-02-01       Impact factor: 3.042

5.  Effect of prolonged therapeutic hypothermia on intracranial pressure, organ function, and hospital outcomes among patients with aneurysmal subarachnoid hemorrhage.

Authors:  Lioudmila V Karnatovskaia; Augustine S Lee; Emir Festic; Christopher L Kramer; William D Freeman
Journal:  Neurocrit Care       Date:  2014-12       Impact factor: 3.210

6.  Inhibition of c-Jun N-terminal kinase ameliorates early brain injury after subarachnoid hemorrhage through inhibition of a Nur77 dependent apoptosis pathway.

Authors:  Yuxiang Dai; Wen Zhang; Xiaoming Zhou; Jixin Shi
Journal:  Neurochem Res       Date:  2014-06-14       Impact factor: 3.996

7.  Protective role of p450 epoxyeicosanoids in subarachnoid hemorrhage.

Authors:  Dominic A Siler; Ross P Martini; Jonathan P Ward; Jonathan W Nelson; Rohan N Borkar; Kristen L Zuloaga; Jesse J Liu; Stacy L Fairbanks; Jeffrey S Raskin; Valerie C Anderson; Aclan Dogan; Ruikang K Wang; Nabil J Alkayed; Justin S Cetas
Journal:  Neurocrit Care       Date:  2015-04       Impact factor: 3.210

8.  Early predictors of prolonged stay in a critical care unit following aneurysmal subarachnoid hemorrhage.

Authors:  Christopher D Witiw; George M Ibrahim; Aria Fallah; R Loch Macdonald
Journal:  Neurocrit Care       Date:  2013-06       Impact factor: 3.210

9.  Antibiotic-impregnated versus silver-bearing external ventricular drainage catheters: preliminary results in a randomized controlled trial.

Authors:  K M L Winkler; C M Woernle; M Seule; U Held; R L Bernays; E Keller
Journal:  Neurocrit Care       Date:  2013-04       Impact factor: 3.210

Review 10.  [Aneurysmal subarachnoid hemorrhage].

Authors:  P Kellner; D Stoevesandt; J Soukup; M Bucher; C Raspé
Journal:  Anaesthesist       Date:  2012-09       Impact factor: 1.041

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.